Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Nanologica
Nanologica
Activities:
Manufacturing
X
LinkedIn
Trending Articles
Innovation in generics: increased efficiency through peptide API synthesis expertise
Leading Swiss pharmaceutical company Bachem explains the benefits of converging LPPS in the manufacturing of gonadotropin-releasing hormone (GnRH) analogues
COVID-19 still a significant risk for the immunocompromised, study finds
AstraZeneca's INFORM study highlights the persistent danger of COVID-19 for the immunocompromised despite the vaccination scheme
US court lifts modified consent decree on Xellia’s Cleveland facility
The Modified Consent Decree imposed on Xellia's Cleveland facility in 2016 has been vacated, receiving a VAI
Lonza's AI-enabled small molecule development tool launches
The company's AI-enabled Route Scouting Service will optimise synthetic route identification when identifying novel APIs
Autoscribe Informatics’ new Australia office supports business growth
The company's move to West Lakes Adelaide expands its ability to service the Asia Pacific region in digitalising laboratory information
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Distribution
Nanologica delivers non-silica based purification media to a customer in Asia
Nanologica has made the first delivery of the company's non-silica-based purification media NLAB Siv to a customer in Asia, with a value of over SEK 4m
Manufacturing
Sterling Pharma to scale-up Swedish preparative chromatography tech
Sterling will produce the large volumes of NLAB Saga chromatography material needed by Yunbo Technology to perform preparative chromatography
Manufacturing
Nanologica and Sterling partnership furthers new business venture
The silica developer and manufacturer has entered into a service agreement with a global contract development and manufacturing organisation for the large-scale production of silica particles
Research & Development
Nanologica joins €10m EU project to develop tuberculosis treatments
GSK leads four-year Orchid project
Subscribe now